Toggle navigation
Home
About Us
Pipeline
Collaborations
Investors
Media Center
News Releases
Publications
Events
Careers
Contact Us
Site Map
Home
About Us
Pipeline
Collaborations
Investors
Media Center
News Releases
Publications
Events
Careers
Media Center
News Releases
Publications
Press Releases
Title Filter
Display #
5
10
15
20
25
30
50
100
All
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-year 2020 Financial Results Conference Call and Webcast on March 10, 2021
Mar 04, 2021
Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure
Jan 14, 2021
Lexicon Pharmaceuticals to Participate in the 39th Annual J.P. Morgan Healthcare Conference
Jan 06, 2021
Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia
Dec 31, 2020
Lexicon Pharmaceuticals Enters Data Collaboration with AC Bioscience
Dec 16, 2020
Lexicon Announces Offering of Common Stock
Dec 11, 2020
Lexicon Pharmaceuticals Receives Fast Track Designation from the FDA for LX9211 for Diabetic Peripheral Neuropathic Pain
Dec 11, 2020
Results from Soloist and Scored Outcomes Studies Presented at Late-breaking Science Session of American Heart Association Scientific Sessions and Published in the New England Journal of Medicine
Nov 16, 2020
Lexicon Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference
Nov 16, 2020
Lexicon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical Update
Oct 29, 2020
1
2
3
4
...
6
7
8
9
10
Copyright
©
2020, Lexicon Pharmaceuticals, Inc. All Rights Reserved
Privacy Policy
Terms of Use
Vendor Terms
Contact Us
Sitemap